We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $455M
1-Year Est. Return 218.66%
This Fund
S&P 500
This Quarter Est. Return
+17.66%
1 Year Est. Return
+218.66%
3 Year Est. Return
+1,489.77%
5 Year Est. Return
+4,348.98%
10 Year Est. Return
+169,910.37%
AUM
$139M
AUM Growth
-$36.7M
Cap. Flow
-$54M
Cap. Flow %
-38.93%
Top 10 Hldgs %
19.06%
Holding
117
New
26
Increased
16
Reduced
43
Closed
32

Top Buys

Rank Stock Value
1
LAD icon
Lithia Motors
LAD
+$2.3M
2
RGEN icon
Repligen
RGEN
+$1.87M
3
GIMO
Gigamon Inc.
GIMO
+$1.82M
4
ATRC icon
AtriCure
ATRC
+$1.75M
5
AMN icon
AMN Healthcare
AMN
+$1.73M

Sector Composition

Rank Sector Weight
1 Technology 29.75%
2 Healthcare 29.34%
3 Consumer Discretionary 16.41%
4 Financials 9.24%
5 Industrials 4.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMPV
1
DELISTED
Imperva, Inc.
IMPV
$3.16M 2.28%
46,649
-10,345
-18% -$571K
QTWO icon
2
Q2 Holdings
QTWO
$3.87B
$2.95M 2.13%
104,488
-26,420
-20% -$618K
MANH icon
3
Manhattan Associates
MANH
$12.5B
$2.75M 1.98%
46,107
-16,945
-27% -$938K
LOGM
4
DELISTED
LogMein, Inc.
LOGM
$2.73M 1.97%
42,401
-15,580
-27% -$976K
WAL icon
5
Western Alliance Bancorporation
WAL
$8.83B
$2.62M 1.89%
77,641
-14,840
-16% -$473K
AMSG
6
DELISTED
Amsurg Corp
AMSG
$2.46M 1.78%
35,199
+6,170
+21% +$412K
GIII icon
7
G-III Apparel Group
GIII
$1.17B
$2.46M 1.77%
34,943
-12,755
-27% -$781K
BFAM icon
8
Bright Horizons
BFAM
$3.42B
$2.45M 1.77%
42,440
+8,190
+24% +$447K
LAD icon
9
Lithia Motors
LAD
$8.5B
$2.44M 1.76%
+21,595
New +$2.3M
SYNH
10
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$2.4M 1.73%
59,845
-21,485
-26% -$741K
BOOT icon
11
Boot Barn
BOOT
$4.67B
$2.4M 1.73%
74,840
+7,455
+11% +$195K
SKX
12
DELISTED
Skechers
SKX
$2.37M 1.71%
64,665
-23,265
-26% -$747K
OZK icon
13
Bank OZK
OZK
$5.5B
$2.36M 1.7%
51,539
+3,915
+8% +$166K
THRM icon
14
Gentherm
THRM
$1.25B
$2.31M 1.67%
42,154
-9,400
-18% -$498K
PLAY icon
15
Dave & Buster's
PLAY
$303M
$2.31M 1.66%
63,887
+8,195
+15% +$275K
CAVM
16
DELISTED
Cavium, Inc.
CAVM
$2.3M 1.66%
33,479
-18,925
-36% -$1.33M
HW
17
DELISTED
Headwaters Inc
HW
$2.27M 1.64%
124,790
-36,890
-23% -$698K
PCTY icon
18
Paylocity
PCTY
$8.08B
$2.26M 1.63%
63,078
-22,610
-26% -$728K
LDRH
19
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$2.26M 1.63%
52,206
-5,406
-9% -$215K
PFPT
20
DELISTED
Proofpoint, Inc.
PFPT
$2.23M 1.61%
35,079
-22,520
-39% -$1.32M
IDTI
21
DELISTED
Integrated Device Technology I
IDTI
$2.22M 1.6%
102,265
-36,080
-26% -$778K
BLOX
22
DELISTED
Infoblox Inc
BLOX
$2.18M 1.57%
83,260
+7,420
+10% +$187K
RGEN icon
23
Repligen
RGEN
$9.46B
$2.11M 1.52%
+51,050
New +$1.87M
AMN icon
24
AMN Healthcare
AMN
$1.31B
$2.09M 1.51%
+66,200
New +$1.73M
SFS
25
DELISTED
Smart & Final Stores, Inc.
SFS
$2.08M 1.5%
116,556
+9,505
+9% +$169K

Similar funds

Lisanti Capital Growth's Q2 2015 Portfolio in Review

As of Q2 2015, Lisanti Capital Growth held 117 positions worth $139M, down 21% from $175M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth withdrew a net $54M in Q2 2015, closing 32 positions and reducing 43 holdings. Its most notable exit was Qualys, an estimated $3.57M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Lisanti Capital Growth opened a new position in Lithia Motors worth $2.44M.

  • Lisanti Capital Growth's largest Q2 2015 buy was Lithia Motors: 21,595 shares worth $2.44M.
  • Lisanti Capital Growth added most to Neurocrine Biosciences in Q2 2015, an estimated $777K increase.
  • Lisanti Capital Growth's biggest Q2 2015 reduction was XPO, cutting an estimated $2.49M.
  • Lisanti Capital Growth fully exited Qualys in Q2 2015, selling an estimated $3.57M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $139M portfolio in Q2 2015.
  • Lisanti Capital Growth opened 26 new positions and closed 32 in Q2 2015.
  • Lisanti Capital Growth's portfolio value fell 21% quarter-over-quarter to $139M.

Based on Lisanti Capital Growth's 13F filing for Q2 2015, filed 24 Jul 2015.